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Atypical Mechanism of Regulation
of the Wrch-1 Rho Family Small GTPase
(Figure 1A). Exchange with mantGMPPNP was even
more rapid and occurred completely within 30 s (data
not shown). In contrast, WT Cdc42 exchange occurred
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The mechanism of Rho guanine nucleotide exchangeSummary
factor (GEF) action involves displacement of the GTPase-
associated Mg2 ion. This effect is mimicked in vitro byRho family GTPases are GDP/GTP-regulated molecu-
addition of excess EDTA to the solution [6], and welar switches that regulate signaling pathways control-
observed that EDTA treatment of Cdc42 resulted in aling diverse cellular processes [1, 2, 3]. Wrch-1 was
10-fold increase in the rate of nucleotide exchangeidentified as a Wnt-1 regulated Cdc42 homolog, upreg-
(kobs  0.01 s1). Unexpectedly, Wrch-1 and N Wrch-1ulated by Wnt1 signaling in Wnt1-transformed mouse
showed decreases in fluorescence intensity of approxi-mammary cells [4], and was able to promote formation
mately 75% from their initial levels (kobs  0.05 s1) (Fig-of filopodia and activate the PAK serine/threonine ki-
ure 1B), suggesting that the nucleotide was releasednase. Wrch-1 shares significant sequence and func-
rather than exchanged from the protein. Fluorescenttional similarity with the Cdc42 small GTPase. How-
anisotropy measurements confirmed this hypothesisever, Wrch-1 possesses a unique N-terminal 46 amino
(Figure 1C), showing an increase of nucleotide binding toacid sequence extension that contains putative Src
Wrch-1 and Cdc42; yet, upon addition of EDTA, Wrch-1-homology 3 (SH3) domain-interacting motifs. We de-
related anisotropy decreased, whereas Cdc42-relatedtermined the contribution of the N terminus to Wrch-1
anisotropy increased. Therefore, the release of protein-regulation and activity. We observed that Wrch-1 pos-
bound Mg2 caused a loss of Wrch-1 nucleotide bindingsesses properties that distinguish it from Cdc42 and
and exchange activity. Consequently, Cdc42 andother Rho family GTPases. Unlike Cdc42, Wrch-1 pos-
Wrch-1 exhibit distinct properties of intrinsic and GEF-sesses an extremely rapid, intrinsic guanine nucleo-
mediated nucleotide exchange and that the usualtide exchange activity. Although the N terminus did
method of nucleotide-loading recombinant small GTPasesnot influence GTPase or GDP/GTP cycling activity
results in inactive Wrch-1.in vitro, N-terminal truncation of Wrch-1 enhanced its
ability to interact with and activate PAK and to cause
growth transformation. The N terminus associated
Wrch-1 Hydrolyzes GTP Independentwith the Grb2 SH3 domain-containing adaptor protein,
of the N-Terminal Sequenceand this association increased the levels of active
To assess the Wrch-1 intrinsic GTP hydrolysis activity,Wrch-1 in cells. We propose that Grb2 overcomes
we utilized the MDCC-phosphate binding protein (PBP)N-terminal negative regulation to promote Wrch-1 ef-
probe [7] to report on Pi produced from single-turnoverfector interaction. Thus, Wrch-1 exhibits an atypical
GTP hydrolysis in vitro and a glutathione S-transferasemodel of regulation not seen in other Rho family
fusion protein containing the GTP-dependent bindingGTPases.
domain of PAK (GST-PAK-RBD) for pull-down of GTP-
bound Wrch-1 for in vivo analysis. Cdc42 and Wrch-1,
Results and Discussion as well as N Wrch-1, showed similar exponential rates
of hydrolysis (kobs  0.001 s1 at 25C) (Figure 2A). Thus,
Wrch-1 Possesses Rapid Intrinsic Guanine Wrch-1 hydrolyzes GTP with similar kinetics to Cdc42,
Nucleotide Exchange Activity Independent and this activity is not influenced by the N-terminal ex-
of N-Terminal Sequences tension. We extended these analyses in vivo and evalu-
In contrast to Cdc42, human Wrch-1 contains N- and ated the GTP-bound state of WT and a putative GTPase-
C-terminal extensions of 46 and 21 amino acids, respec- deficient mutant of Wrch-1 in vivo. We generated a
tively. We have examined the role of the N terminus in Q107L mutant of Wrch-1 (analogous to the Q61L GTPase-
Wrch-1 GDP/GTP regulation and effector interaction. deficient activating mutant of Cdc42). WT and Wrch-1
First, we determined the in vitro guanine nucleotide (Q107L) proteins were expressed in NIH 3T3 cells (Figure
binding and hydrolysis activities of wild-type (WT) and 2B). Under starved conditions, the amount of Wrch-1
N-terminally truncated Wrch-1 (N) in vitro. Surprisingly, precipitated by GST-PAK-RBD was considerably less
both WT and N Wrch-1 completely exchanged than that seen with Wrch-1 (Q107L). In the presence
mantGDP rapidly within 2 min (both kobs  0.01 s1) of serum, the amount of GTP-bound WT Wrch-1 was
increased but was still lower than the level seen with the
Q107L mutant. Therefore, Wrch-1 is an active GTPase*Correspondence: cjder@med.unc.edu
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Figure 1. Wrch-1 and Cdc42 Exhibit Very Distinct Interactions with Guanine Nucleotides In Vitro
(A) Wrch-1 possesses a rapid guanine nucleotide exchange rate in vitro. GST-Wrch-1 or GST-Cdc42 was added to a solution of excess mant-
GDP, and the changes in mant fluorescent intensity followed.
(B) Wrch-1 demonstrates unusual properties in the absence of bound Mg2. GST-Wrch-1 or GST-Cdc42 protein was incubated with excess
mant-GDP before excess EDTA was added (arrow). The subsequent changes in fluorescent intensity followed.
(C) Wrch-1 releases nucleotide on loss of Mg2. GST-Wrch-1 or GST-Cdc42 protein was added to a solution containing excess mant-GDP
and the fluorescent anisotropy of the Mant-GDP measured after 2 min of incubation. Excess EDTA was added to the solution and the
fluorescent anisotropy was then measured after another 2 min of incubation. Data shown are representative of three separate determinations.
in vivo, and the Q107L substitution renders Wrch-1 both N-Terminal Truncation of Wrch-1 Increases
Effector Association and ActivationGTPase-deficient and GTP-bound. A serum factor may
also stimulate Wrch-1 activation. and Transforming Activity
We next determined if the N terminus was able to influ-
ence the activation of Wrch-1 in vivo. Full length and
N versions of WT and Wrch-1 Q107L were expressed
in serum-starved cells, and the amount of GTP-bound
Wrch-1 was assessed (Figure 3A). N Wrch-1 (Q107L)
showed the highest level of precipitated protein, fol-
lowed by Wrch-1 (Q107L), N Wrch-1, and, finally, WT
Wrch-1. Because our earlier analyses indicated that ex-
change was extremely rapid and independent of the N
terminus, the increased level of precipitated protein
seen with both N protein forms suggests that the N
terminus may serve as a negative regulator of effector
association, partially independent of nucleotide state.
This suggests that Wrch-1 may be regulated by other,
non-GEF, mechanisms, such as protein-protein interac-
tions with its N terminus.
To confirm that the N terminus influences effector
association, we compared the ability of the different
Wrch-1 proteins to cause activation of endogenous
PAK1 (Figure 3B). Using a phosphospecific antibody
that specifically recognizes activated PAK1 auto-phos-
phorylation at serine 144 [8], we found that PAK phos-
phorylation was dependent on both the nucleotide state
and the presence of the N-terminal extension—mirroring
our pull-down analyses. Wrch-1 (Q107L) caused a higher
level of PAK phosphorylation than wild-type Wrch-1,
and each N-terminally truncated protein caused more
PAK phosphorylation than its full length counterpart.
Therefore, the N-terminal extension of Wrch-1 plays an
inhibitory role in the activation of PAK1.
We anticipated that N-terminal truncation may alsoFigure 2. Wrch-1 Is an Active GTPase
enhance Wrch-1 biological activity. Like Cdc42, Wrch-1(A) Wrch-1 GTPase activity in vitro is not altered by deletion of the N
causes growth transformation of NIH 3T3 mouse fibro-terminus. GST-Wrch-1, GST-N Wrch-1, or GST-Cdc42, preloaded
blasts (A.C.B., C.J.D., and A.D.C., unpublished data), sowith GTP, was incubated with MDCC-PBP. Increases in fluorescent
intensity of the MDCC-PBP then followed. we evaluated the ability of NIH 3T3 cells stably express-
(B) The Q107L substitution impairs Wrch-1 GTPase activity in vivo. ing the different Wrch-1 proteins to proliferate in an
NIH 3T3 cells transfected with HA epitope-tagged Wrch-1, Wrch-1 anchorage-independent environment (Figure 3C). Cells
(Q107L), and Myc epitope-tagged Cdc42 and Cdc42 Q61L were expressing WT Wrch-1 did not increase the number of
maintained in serum-starved or complete-growth media for 24 hr.
colonies formed compared to vector-transfected cellsWrch-1 or Cdc42 proteins were precipitated with GST-PAK-RBD
(Figure 3D). N Wrch-1-expressing cells demonstratedand detected by Western blot analysis; quantitation is shown below.
Data shown are representative of three individual experiments. an approximately 3-fold increase in the number of colo-
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Figure 3. Deletion of the N Terminus Enhances Wrch-1 Effector Binding and Activation, and Transforming Activity
(A) Deletion of the N terminus enhances association with the PAK-RBD in vitro. Expression vectors encoding HA epitope-tagged Wrch-1,
Wrch-1 (Q107L), N Wrch-1, or N Wrch-1 (Q107L) were transiently expressed in serum-starved cultures of NIH 3T3 cells for 24 hr. The GST-
PAK-RBD-precipitated proteins were subjected to Western blot analysis; quantitation is shown below.
(B) N-terminal deletion enhances Wrch-1 activation of PAK in vivo. Cell lysates of NIH 3T3 cells stably expressing the indicated Wrch-1 proteins
were subjected to SDS-PAGE and Western blot analysis using antibodies for anti-PAK1/2/3 or anti-phospho-PAK1(Ser 144)/PAK2(Ser 141).
Quantitation is shown below.
(C) N-terminal deletion enhances activated Wrch-1 induction of anchorage-independent growth. Stable NIH 3T3 cell lines expressing Wrch-1
(Q107L), N Wrch-1, and N Wrch-1 (Q107L) were seeded in soft agar. After 14–21 days, colonies formed were stained, photographed, and
quantified. The number of large colonies (greater than 16 cell diameters) were also counted and captured photographically after MTT staining.
(D) Quantitation of data shown in panel (C). Data shown are representative of two separate experiments performed in triplicate.
(E) N-terminal truncation of Wrch-1 contributes to the nucleotide independent binding to PAK in vitro. NIH 3T3 cells transiently expressing
either full-length Wrch-1 or N Wrch-1 proteins were maintained in growth medium (0.5% calf serum) for 24 hr. Cell lysates were incubated
with GST-PAK-RBD with excess of desired nucleotide (1 mM GDP or 1 mM GMPPNP). Samples were then subjected to SDS-PAGE and
Western blot analysis.
nies compared to WT Wrch-1 cells. Wrch-1 (Q107L)- Together, the PAK1 activation, transformation, and
expressing cells readily formed a 6-fold increase in colo- saturated-nucleotide precipitation data indicate that the
nies, and N Wrch-1 (Q107L)-expressing cells formed a binding of Wrch-1 to PAK (both the isolated RBD and
ten-fold increase in total colony number over WT Wrch-1 full length protein) is affected directly by two factors:
expressing cells, (and a 5-fold increase in the number the presence of the N-terminal extension (important in
of large colonies compared to Wrch-1 [Q107L]) (Figure effector binding) and the bound nucleotide state (which
3C). These data suggest that Wrch-1-transforming activ- may be important in effector activation). Deletion of the
ity is regulated by both GDP/GTP cycling and the pres- N terminus partially activates Wrch-1, although both
ence of the N terminus. N-terminal deletion and GTP binding act synergistically
To confirm the roles of bound nucleotides and to produce the most active form of Wrch-1. Based on
N-terminal extension in effector binding, cells express- our analyses with the PAK-RBD, Wrch-1 exists predomi-
ing Wrch-1 and N Wrch-1 were precipitated with GST- nantly as a GDP-bound protein in vivo, and because the
PAK-RBD in the presence of excess GDP or GMPPNP N terminus of Wrch-1 inhibits effector interaction, this
(Figure 3E). Consistent with previous observations, Cdc42 assay may provide a misleading indication of the nucleo-
demonstrated nucleotide-dependent binding. Wrch-1• tide state of Wrch-1.
GDP was precipitated in significantly lower amounts
than Wrch-1•GMPPNP, consistent with the GTP-bound
The N Terminus of Wrch-1 Associatesform of Wrch-1 being the activated form. N Wrch-1•
with the SH3 Domain-ContainingGDP and N Wrch-1•GMPPNP associated with the
Grb2 Adaptor ProteinPAK-RBD in high amounts (Figure 3E), although the
The data above suggest that the N terminus of Wrch-1GMPPNP form consistently associated at a slightly higher
may serve as a novel intramolecular regulator of Wrch-1level. These results suggest that the regulation of effector
function. The presence of proline-rich motifs in the Nassociation with Wrch-1 is complex and regulated by both
the N terminus of Wrch-1 and binding of GTP. terminus suggests that SH3 domain-containing proteins
Wrch-1 Rho GTPase Regulation
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Figure 4. Wrch-1 Associates with Grb2, Nck and PLC In Vitro but Only Grb2 In Vivo
(A) Wrch1 associates with specific SH3 domains. Wrch-1 and Wrch-1 (Q107L) were transiently expressed in NIH 3T3 cells for 24 hr. Cell lysate
was incubated with agarose-GST fusion proteins containing full-length (*) or isolated SH3 domains (§), and the precipitate was subjected to
Western blot analysis.
(B) The N terminus of Wrch-1 is required for SH3 domain association. Wrch-1 and N Wrch-1 were transiently expressed in NIH 3T3 cells.
The lysate was incubated with agarose-GST-SH3 proteins before Western blot analysis of the precipitate with anti-HA antibody.
(C) The association of the SH3 domains of Grb2, Nck, and PLC to the N terminus of Wrch-1 is direct. His6-C or N Wrch-1 was incubated
with the GST-SH3 domain constructs of Grb2, Nck, PLC, and p67, and the precipitate was subjected to Western blot analysis.
(D) Wrch-1 associates with Grb2 but not Nck or PLC in vivo. Wrch-1 (Q107L) or N Wrch-1 (Q107L) were transiently expressed in NIH 3T3
cells, either alone or coexpressed with FLAG-Nck. Cells were lysed and HA-tagged proteins were immunoprecipitated before Western blot
analysis.
(E) Coexpression of Grb2 increases Wrch-1 binding to PAK-RBD in vivo. Cell lysate from NIH 3T3 cells transiently expressing either Wrch-1
alone or with full-length Grb2, the SH2/SH3 domains of Grb2, or full-length Nck were incubated with GST-PAK-RBD before Western blot
analysis.
may interact with the N terminus. These sequences cleotide bound state, although there was a greater level
of binding to GTP-bound Wrch-1, which suggests that(PAFPDR at residue 8, PPVPPRR at residue 20, and
PPGEPGGR at residue 38) closely match the consensus GDP/GTP cycling may somehow regulate the N termi-
nus. Using His6-tagged C and N Wrch-1, we per-binding motifs of the SH3 domains of Grb2 (PXXPXR),
phospholipase C  (PLC) (PPVPPRP), and Nck (PXXPX formed in vitro association analyses with the GST-SH3
domains (Figure 4C). Together, these data show thatRXXS), respectively [9]. To evaluate whether these or
other SH3 domain-containing proteins associate with the interaction between Wrch-1 and Grb2 and Nck and
PLC is direct and absolutely requires the N terminus.the N terminus of Wrch-1, we expressed HA epitope-
tagged versions of full-length or N Wrch-1 in NIH 3T3 To validate that these interactions occur in vivo, we
immunoprecipitated HA-Wrch-1 proteins, followed bycells. Cell lysates were incubated with GST fusion pro-
teins containing isolated SH3 domains or SH3 domain- western blot analyses to detect coimmunoprecipitated
endogenous Grb2, PLC or exogenously co-expressedcontaining, full-length proteins. As expected, Wrch-1
was precipitated by the SH3 domains of Grb2, Nck, Nck. Endogenous Grb2 was co-immunoprecipitated
from cells expressing Wrch-1; surprisingly, N Wrch-1,and PLC, and activated Wrch-1 was precipitated to a
slightly greater extent (Figure 4A), and no association exogenous Nck, and endogenous PLC showed no as-
sociation with either form (Figure 4D). The precipitationof N Wrch-1 with the GST-SH3 domains was observed
(Figure 4B). Association was not dependent on the nu- of Grb2 with N Wrch-1 is most likely indirect via Grb2
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2. Burridge, K., and Wennerberg, K. (2004). Rho and Rac takeassociation with PAK because we found that Grb2 asso-
center stage. Cell 116, 167–179.ciation with Wrch-1 in vitro required the N terminus.
3. Raftopoulou, M., and Hall, A. (2004). Cell migration: RhoWe then speculated that coexpression of Grb2 and
GTPases lead the way. Dev. Biol. 265, 23–32.
Wrch-1 may enhance Wrch-1 effector interaction. To 4. Tao W, Pennica D, Xu L, Kalejtar RF, Levine AJ. (2001). Wrch-1,
test this, full-length Grb2 or Nck was coexpressed with a novel member of the Rho gene family that is regulated by
Wrch-1 in NIH 3T3 cells, and GST-PAK-RBD was used Wnt-1. Genes Dev. 15,1 796–1807.
5. Rossman, K.L., Worthylake, D.K., Snyder, J.T., Cheng, L.,to precipitate Wrch-1 from the cell lysate. Coexpression
Whitehead, I.P., and Sondek, J. (2002). Functional analysis ofof Grb2 but not Nck caused a significant increase in the
cdc42 residues required for guanine nucleotide exchange. J.levels of precipitated Wrch-1 (Figure 4E), supporting
Biol. Chem. 277, 50893–50898.our proposal that Grb2 relieves the negative regulatory
6. Satoh, T., Nakamura, S., Nakafuku, M., and Kaziro, Y. (1998).
function of the N terminus to promote effector interac- Studies on ras proteins. Catalytic properties of normal and acti-
tion and Wrch-1 activation. vated ras proteins purified in the absence of protein denatur-
In conclusion, we suggest that the N terminus of ants. Biochim. Biophys. Acta 949, 97–109.
7. Brune, M., Hunter, J., Corrie, J., and Webb, M. (1994). Direct,Wrch-1 acts as a negatives regulator of Wrch-1 interac-
real-time measurement of rapid inorganic phosphate releasetion with PAK and other effectors, and Grb2 interaction
using a novel fluorescent probe and it’s application to actomyo-with the N terminus relieves this inhibition to promote
sin subfragment 1 ATpase. Biochemistry 33, 8262–8271.Wrch-1 effector activation and potential GDP/GTP ex-
8. Chong, C., Tan, L., Lim, L., and Manser, E. (2001). The mecha-
change. Whereas the classical Rho family GTPases are nism of PAK activation. Autophosphorylation events in both
regulated by primarily by GAP- and GEF-stimulated regulatory and kinase domains control activity. J. Biol. Chem.
GDP/GTP cycling, Wrch-1 function is regulated by an 276, 17347–17353.
9. Cesareni, G., Panni, S., Nardelli, G., and Castagnoli, L. (2002).intramolecular auto-inhibitor mechanism that regulates
Can we infer peptide recognition specificity mediated by SH3effector association and potentially rapid exchange, al-
domains? FEBS Lett. 513, 38–44.though regulation by a GAP (such as the Rheb GTPases
10. Li, Y., Corradetti, M.N., Inoki, K., and Guan, K.L. (2004). TSC2:[10]) remains a likely possibility. We have also deter-
Filling the GAP in the mTOR signaling pathway. Trends Bio-
mined that a Wrch-1-related protein, Chp/Wrch-2 [11], chem. Sci. 29, 32–38.
exhibits a similar mechanism of regulation (Chenette et 11. Aronheim, A., Broder, Y.C., Cohen, A., Fritsch, A., Belisle, B.,
al., personal communication) – deletion of its proline- and Abo, A. (1998). Chp, a homologue of the GTPase Cdc42Hs,
activates the JNK pathway and is implicated in reorganizing therich N-terminal extension, rather than GTPase-defi-
actin cytoskeleton. Curr. Biol. 8, 1125–1128.ciency, caused potent activation of Chp transforming
12. Ye, K., Hurt, K.J., Wu, F.Y., Fang, M., Luo, H.R., Hong, J.J.,activity. While this mechanism of regulation may be
Blackshaw, S., Ferris, C.D., and Snyder, S.H. (2000). Pike. Aunique for Rho family of GTPases, it may not be unique
nuclear gtpase that enhances PI3kinase activity and is regulated
to other GTPases. Like Wrch-1, the PIKE [12, 13] and by protein 4.1N. Cell 103, 919–930.
dynamin [14] GTPases contain proline-rich flanking se- 13. Ye, K., Aghdasi, B., Luo, H.R., Moriarity, J.L., Wu, F.Y., Hong,
quences, which may be regulated by SH3 domains. J.J., Hurt, K.J., Bae, S.S., Suh, P.G., and Snyder, S.H. (2002).
Phospholipase C gamma 1 is a physiological guanine nucleotidePIKE, a nuclear GTPase, contains proline-rich regions
exchange factor for the nuclear GTPase PIKE. Nature 415,that are N-terminal of the GTPase domain, which associ-
541–554.ate with the SH3 domain of PLC and increase PIKE
14. Gout, I., Dhand, R., Hiles, I.D., Fry, M.J., Panayotou, G., Das,activity. We suggest that the SH3 domain of PLC acts
P., Truong, O., Totty, N.F., Hsuan, J., and Booker, G.W. (1993).
by relieving steric hindrance and promoting a more ac- The GTPase dynamin binds to and is activated by a subset of
tive state. Future studies to determine the structure of SH3 domains. Cell 75, 25–36.
Wrch-1 will be required to establish the mechanism by
which the N terminus regulates effector interaction.
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Supplemental Data including Experimental Procedures are avail-
able at http://www.current-biology.com/cgi/content/full/14/22/
2052/DC1/.
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